Metformin or tranexamic acid cream for melasma
Part of Skin clinical trials.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You have melasma on your face diagnosed by a doctor
- You have not used any melasma treatments (cream or pills) in the last 4 weeks
- You are not pregnant or breastfeeding
- You are willing to try one of two study creams
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments for melasma, a common skin condition causing dark patches on the face. One treatment uses an injection into the affected skin (tranexamic acid), while the other uses a chemical peel (mandelic acid). The study aims to see which works better and is safer for people with darker skin tones.
This study compares a 30% metformin cream to a standard combination cream (Kligman's regimen) for treating melasma in women. It aims to see which treatment works better at lightening dark patches and improving skin tone.
This study tests whether adding an oral medication (tranexamic acid) to a standard triple cream for melasma works better than the cream alone. It may help if you have medium-to-severe melasma and are generally healthy.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This trial tests whether a cream containing metformin or ketotifen can help lighten melasma patches on the face. Both creams are applied to the skin and compared against each other.
This study tests whether combining oral tranexamic acid with a special skin needling treatment helps reduce melasma (dark facial patches). It is designed for women aged 18-50 who have melasma and are not pregnant or on certain medications.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.